Results 221 to 230 of about 4,998,947 (297)
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham +21 more
wiley +1 more source
Mass spectrometry-based peripheral blood proteomics for biomarker discovery in idiopathic pulmonary fibrosis. [PDF]
Menon AA +10 more
europepmc +1 more source
Decrypting cancer's spatial code: from single cells to tissue niches
Spatial transcriptomics maps gene activity across tissues, offering powerful insights into how cancer cells are organised, switch states and interact with their surroundings. This review outlines emerging computational, artificial intelligence (AI) and geospatial approaches to define cell states, uncover tumour niches and integrate spatial data with ...
Cenk Celik +4 more
wiley +1 more source
Proteome-wide and network pharmacology integration identifies sunitinib as a potential therapeutic for type 2 diabetes targets. [PDF]
Kong Y, Zhu HW, Tong HX, Shi L, Yu H.
europepmc +1 more source
THE FATE OF PROTEIN DIGESTION PRODUCTS IN THE BODY
Donald D. Van Slyke, G.M. Meyer
openalex +1 more source
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan +9 more
wiley +1 more source
Protein fingerprints of brain-derived extracellular vesicles predict types of tau pathology. [PDF]
Espourteille J +11 more
europepmc +1 more source
MAINTENANCE EXPERIMENTS WITH ISOLATED PROTEINS
Thomas B. Osborne +2 more
openalex +1 more source

